Biomerica (BMRA) executive compensation, 2025 proxy

Zackary Irani, Chairman & Chief Executive Officer, was paid $201,034 in 2025, down 44% from $360,103 the year before.

Filed
October 20, 2025
Annual meeting
December 12, 2025
Pay year
2025
Named executives
3
CEO total pay
$201,034-44% vs prior year
CEO pay in equity
39%$78,438 in awards
CEO stock awards
$78,43831,250 restricted shares
CFO total compensation
$311,769
Barbieri total compensation
$127,928
CEO 2024 total
$360,103

How Irani was paid

$201,034 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary61%Stock awards39%

Named executive officers

ExecutiveTotal
Zackary IraniChairman & Chief Executive Officer$201,034
Allen BarbieriDirector, Executive Vice Chairman & Secretary$127,928
Gary LuChief Financial Officer$311,769

What changed and why

  • $201K2025 CEO total compensation was $201,034, compared with $360,103 in 2024.
  • $123KCEO salary was $122,596 after a temporary reduction to $75,000 during fiscal 2025.
  • $78,43831,250 restricted shares awarded to the CEO carried grant-date fair value of $78,438.
  • No management incentive cash bonuses were paid to named executive officers in fiscal 2025.
  • $312K$311,769 was Gary Lu’s total compensation, the highest among the 2025 named executives.

Other Biomerica proxy statements

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.